C9H9F2N.C4H6O6
Neat
169.18 150.09
220352-39-6; (1R, 2S)-2-(3, 4-Difluorophenyl)cyclopropanamine (2R, 3R)-2, 3-Dihydroxysuccinate; MFCD22648279; C13H15F2NO6; (1R, 2S)-2-(3, 4-difluorophenyl)cyclopropan-1-amine;(2R, 3R)-2, 3-dihydroxybutanedioic acid; Cyclopropanamine, 2-(3, 4-difluorophenyl)-(1R, 2S)-(2R, 3R)-2, 3-dihydroxybutanedioate; (1R, 2S)-2-(3, 4-Difluorophenyl)cyclopropanamine-(2R, 3R)-2, 3-dihydroxysuccinate; Ticagrelor Impurity 251; SCHEMBL29839263; DTXSID40680608; AKOS016004944; DS-3824; EX-7183; (1R, 2S)-2-(3, 4-Difluorophenyl)cyclopropanamine(2R, 3R)-2, 3-Dihydroxysuccinate; AC-37268; CS-0157171; C74114; (1R, 2S)-2-(3, 4-difluorophenyl)cyclopropanamine L-Tartaric acid; (1R, 2S)-2-(3, 4-difluorophenyl)cyclopropan-1-amine (2R, 3R)-2, 3-dihydroxysuccinate; (1R, 2S)-2-(3, 4-difluorophenyl)cyclopropan-1-amine; (2R, 3R)-2 and 3-dihydroxybutanedioic acid
(2R, 3R)-2, 3-dihydroxybutanedioic acid;trans-(1R, 2S)-2-(3 and 4-difluorophenyl)cyclopropan-1-amine
InChI=1S/C9H9F2N.C4H6O6/c10-7-2-1-5(3-8(7)11)6-4-9(6)12;5-1(3(7)8)2(6)4(9)10/h1-3,6,9H,4,12H2;1-2,5-6H,(H,7,8)(H,9,10)/t6-,9+;1-,2-/m01/s1